Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $14.95 Analyst target: $19.40 Upside: 29.77%
Carlsmed, Inc. develops and operates a surgical platform for the treatment of complex adult spinal deformities that enables surgeons to harness clinical intelligence, advanced image recognition, and 3D printing technologies. The company is headquartered in Carlsbad, California.
See the full interactive analysis & chart →Informational only — not investment advice.